"10.1371_journal.pone.0034708","plos one","2012-04-09T00:00:00Z","Michelle Bronze; Kim Steegen; Carole L Wallis; Hans De Wolf; Maria A Papathanasopoulos; Margriet Van Houtte; Wendy S Stevens; Tobias Rinke de Wit; Lieven J Stuyver; on behalf of the ART-A Consortium","Department of Molecular Medicine and Haematology, University of the Witwatersrand, Johannesburg, South Africa; Virco BVBA, Beerse, Belgium; Center for Poverty-related Communicable Diseases (CPCD), PharmAccess Foundation, Academic Medical Center, Amsterdam, The Netherlands","Conceived and designed the experiments: MB KS CLW WSS TRDW LJS. Performed the experiments: MB KS. Analyzed the data: MB KS HDW MVH LJS. Contributed reagents/materials/analysis tools: LJS WSS CLW. Wrote the paper: MB KS MAP LJS. Provided significant comments and editing on the paper: CLW HDW MVH WSS TRDW.","KS, HDW, MVH and LJS are employees of Tibotec-Virco Virology BVBA, a company which commercializes HIV drug resistance testing technology. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2012","04","Michelle Bronze","MB",10,TRUE,6,2,5,4,TRUE,TRUE,TRUE,1,"10",TRUE
